RabPharma
Latest round
- Series A
Last raised
- Aug 2023
Total raised
- Undisclosed
Investors
- 4
About RabPharma
Based in Zhongshan, China, and founded in 2021, RabPharma is a biopharmaceutical company focusing on the research and development of peptide-drug conjugate (PDC). It has reached a collaboration agreement with Regenerative Arthritis & Bone Medicine, Inc. to acquire the rights to develop and commercialize a series of innovative drugs (RABs). It also has partnerships with In October 2022, RAB001 received drug clinical trial approval from the Drug Review Center of the State Drug Administration of China. The company's Chief Scientist Officer, Wei Yao, is a professor at the University of California, Davis, and she has been involved in drug discovery and development for Pfizer, Amgen, GlaxoSmithKline, etc. The company focuses on RAB-002, RAB-003, and RAB-004 as well as YLLs, bone regeneration drugs such as herbal compounds containing hyssop, small molecule drugs for the treatment of osteoarthritis, PR-Inhs and bone-targeted super-nano-carrying drugs, nanoporphyrin analogs, and other new products and the application of new technologies. It has built a technology platform for PDC coupling and high-throughput screening, etc.S. and has been granted the CDE clinical approval in China. It generates revenue through research development and industrialization of new innovative bone and joint drugs.
Who invested in RabPharma
4 investors across 1 round
See all investors in RabPharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 31, 2023
Amount
Undisclosed
Investors
Questions about RabPharma
Who invested in RabPharma?
RabPharma has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has RabPharma raised?
RabPharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did RabPharma last raise money?
RabPharma's most recent round on record is a Series A, in Aug 2023.
What does RabPharma do?
Based in Zhongshan, China, and founded in 2021, RabPharma is a biopharmaceutical company focusing on the research and development of peptide-drug conjugate (PDC).
Where is RabPharma headquartered?
RabPharma is headquartered in Zhongshan, China.
Which VCs invest in companies like RabPharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at RabPharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like RabPharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.